- Home
- TNGX vs EFSCP Comparison
TNGX vs EFSCP Comparison
Compare TNGX & EFSCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- EFSCP
- Stock Information
- Founded
- TNGX 2014
- EFSCP N/A
- Country
- TNGX United States
- EFSCP United States
- Employees
- TNGX N/A
- EFSCP 1221
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- EFSCP Major Banks
- Sector
- TNGX Health Care
- EFSCP Finance
- Exchange
- TNGX Nasdaq
- EFSCP Nasdaq
- Market Cap
- TNGX 735.0M
- EFSCP N/A
- IPO Year
- TNGX N/A
- EFSCP N/A
- Fundamental
- Price
- TNGX $6.64
- EFSCP $21.57
- Analyst Decision
- TNGX Strong Buy
- EFSCP
- Analyst Count
- TNGX 8
- EFSCP 0
- Target Price
- TNGX $15.14
- EFSCP N/A
- AVG Volume (30 Days)
- TNGX 885.7K
- EFSCP N/A
- Earning Date
- TNGX 11-06-2024
- EFSCP N/A
- Dividend Yield
- TNGX N/A
- EFSCP N/A
- EPS Growth
- TNGX N/A
- EFSCP N/A
- EPS
- TNGX N/A
- EFSCP N/A
- Revenue
- TNGX $42,509,000.00
- EFSCP N/A
- Revenue This Year
- TNGX $18.15
- EFSCP N/A
- Revenue Next Year
- TNGX N/A
- EFSCP N/A
- P/E Ratio
- TNGX N/A
- EFSCP N/A
- Revenue Growth
- TNGX 26.16
- EFSCP N/A
- 52 Week Low
- TNGX $6.33
- EFSCP N/A
- 52 Week High
- TNGX $13.01
- EFSCP N/A
- Technical
- Relative Strength Index (RSI)
- TNGX 37.15
- EFSCP 59.74
- Support Level
- TNGX $6.83
- EFSCP $21.56
- Resistance Level
- TNGX $7.47
- EFSCP $22.22
- Average True Range (ATR)
- TNGX 0.37
- EFSCP 0.29
- MACD
- TNGX 0.11
- EFSCP 0.06
- Stochastic Oscillator
- TNGX 27.31
- EFSCP 59.63
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About EFSCP Enterprise Financial Services Corporation Depositary Shares Each Representing a 1/40th Interest in a Share of 5% Fixed Rate Non-Cumulative Perpetual Preferred Stock Series A
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate, and consumer loans.